Vertex Pharmaceuticals (VRTX)

Investing Cash Flow

-$882.80M

TTM · Period ending: · USD

VRTX logo

VRTX Investing Cash Flow

Latest reported-$882.80M
VRTX TTM Cash from Investing (-$9.40M → -$882.80M)
High-resolution chart · PNG

VRTX investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-882,800,000
-1,321,500,000
-945,400,000
-1,479,200,000
-1,710,200,000
-1,689,400,000
-3,770,000,000
-3,834,600,000
-3,604,300,000
-3,444,500,000
-3,141,700,000
-2,079,600,000
-2,346,100,000
-2,103,700,000
-321,100,000
-630,698,000
-299,450,000
-317,591,000
-340,900,000
36,845,000
-158,140,000
-6,587,000
99,388,000
-1,041,350,000
-1,042,412,000
-1,164,514,000
-1,235,318,000
-379,231,000
-180,121,000
-246,229,000
-202,158,000
-182,351,000
-294,918,000
-274,967,000
-437,681,000
-186,416,000
10,831,000
49,396,000
104,469,000
-248,389,000
-384,115,000
-47,890,000
268,856,000
365,485,000
496,965,000
308,404,000
73,959,000
38,641,000
57,632,000
-36,941,000
-54,130,000
14,405,000
-166,359,000
-231,711,000
-425,817,000
-820,749,000
-668,075,000
-425,242,000
212,412,000
430,493,000
406,633,000
274,491,000
7,301,000
-370,781,000
-325,842,000
-450,147,000
-508,732,000
-31,470,000
-177,852,000
-129,069,000
-360,650,000
-146,400,000
138,718,000
48,097,000
405,166,000
-18,870,000
-179,419,000
-45,094,000
-208,471,000
39,766,000
-29,331,000
3,851,000
-1,732,000
68,223,000
134,750,000
137,495,000
107,428,000
101,821,000
67,320,000
14,387,000
119,585,000
98,503,000
110,481,000
80,001,000
-15,962,000
-59,392,000
-15,743,000
-31,116,000
-145,087,000
-259,219,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.